Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S. financial markets. The Company ...
TransMedics Group, Inc. ("TransMedics") , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the ...
Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results